Orthopedic shoes Market By Sole Type (Flatfoot Orthopedic Shoes, Cavus Orthopedic Shoes, Calcaneal Spur Orthopedic Shoes, Varus Orthopedic Shoes, Valgus Orthopedic Shoes, Others) , By Consumer (Men, Women, Kids) By Application (Injuries, Alignment Issues,

Orthopedic shoes Market By Sole Type (Flatfoot Orthopedic Shoes, Cavus Orthopedic Shoes, Calcaneal Spur Orthopedic Shoes, Varus Orthopedic Shoes, Valgus Orthopedic Shoes, Others) , By Consumer (Men, Women, Kids) By Application (Injuries, Alignment Issues, Foot Disorders) By End User (Orthopedic Clinics, Hospitals, Rehabilitation Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The orthopedic shoes market was valued at $3.6 billion in 2023, and is projected to reach $9.2 billion by 2033, growing at a CAGR of 9.8% from 2024 to 2033.

Orthopedic shoes, also known as custom-made therapeutic shoes, are designed with special features intended to provide support, comfort, and stability for individuals with foot, ankle, or lower limb issues. Unlike regular shoes, orthopedic shoes address specific medical conditions such as plantar fasciitis, arthritis, diabetes-related foot complications, and post-surgical rehabilitation needs. Customized insoles, added cushioning, arch support, wider toe boxes, and firmer heel counters are the key features of the that alleviate or prevent foot pain and improve overall foot health.

The growth of the global orthopedic shoes market is driven by alarming rise in prevalence of diabetes, arthritis, and plantar fasciitis coupled with increase in awareness about the benefits associated with orthopedic shoes. According to a 2024 study published in the JAMA Network—a monthly open access medical journal published by the American Medical Association—one-third of the diabetic individuals develop foot ulcers in their lifetime. Approximately 18.6 million individuals worldwide and 1.6 million in the U.S. annually develop foot ulcers. This highlights the urgent need for preventive foot care in diabetic population to reduce amputation risks. In addition, surge in geriatric population significantly contributes toward the market growth. With growing elderly population worldwide, the need for orthopedic footwear has increased as aged individuals often face mobility issues, reduced bone density, and foot deformities that require supportive, comfortable shoes. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, with increase in popularity of fitness and outdoor activities, more individuals are focusing on foot health, which fosters the demand for orthopedic shoes. Furthermore, the expansion of e-commerce and direct-to-consumer options has made orthopedic shoes more accessible to a broader audience, which acts as the key driving force of the global market. However, higher cost of orthopedic shoes as compared to regular footwear restrains the growth of the market. In addition, lack of aesthetic appeal limit their adoption among younger, fashion-conscious consumers, thus hampering the market growth. On the contrary, technological developments in footwear, including improved materials, 3D printing, and custom orthotic solutions, have enabled manufacturers to design more effective, comfortable, and aesthetically appealing orthopedic shoes. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The global orthopedic shoes industry is segmented on the basis of sole type, consumer, application, and end user, and region. By sole type, the market is classified into in flatfoot orthopedic shoes, cavus orthopedic shoes, calcaneal spur orthopedic shoes, varus orthopedic shoes, valgus orthopedic shoes, and others. On the basis of consumer, it is divided into men, women, and kids. Depending on application, it is segregated into injuries, alignment issues, and foot disorders. As per end user, it is fragmented into orthopedic clinics, hospitals, and rehabilitation centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By sole type, the flatfoot orthopedic shoes segment is expected to dominate the market from 2024 to 2033.

On the basis of consumer, the women segment is anticipated to exhibit the highest growth during the forecast period.

Depending on application, the foot disorders segment is projected to emerge as a dominant force in the coming years.

As per end user, the orthopedic clinics segment is likely to lead the orthopedic shoes market in the near future.

Region wise, North America is expected to emerge as the most lucrative market for orthopedic shoes throughout the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global orthopedic shoes market include Enovis Corporation, DARCO International, Inc., MEPHISTO S.A.S, Propet US, Inc, Apex Foot Health Industries, LLC, DUNA-Corradini S.p.A, Vionic Group LLC, Chaneco Limited, Orthofeet, Inc., and Piedro. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Key Market Segments

By Sole Type

Flatfoot Orthopedic Shoes
Cavus Orthopedic Shoes
Calcaneal Spur Orthopedic Shoes
Varus Orthopedic Shoes
Valgus Orthopedic Shoes
Others

By Consumer

Men
Women
Kids

By Application

Injuries
Alignment Issues
Foot Disorders

By End User

Orthopedic Clinics
Hospitals
Rehabilitation Centers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Enovis Corporation
DARCO International, Inc.
MEPHISTO S.A.S
Propet US, Inc
Apex Foot Health Industries, LLC
DUNA-Corradini S.p.A
Vionic Group LLC
Chaneco Limited
Orthofeet, Inc.
Piedro